Iptacopan Hydrochloride Monohydrate
Iptacopan Hydrochloride Monohydrate, marketed under the brand name Fabhalta, is a novel oral medication classified as a complement factor B inhibitor. It is primarily used to treat rare blood and kidney disorders. Reference standards of Iptacopan Hydrochloride Monohydrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


Iptacopan Hydrochloride Monohydrate
Catalogue No.:PA 09 1680000
CAS :
2447007-60-3
Molecular Formula : C25H33ClN2O5
Molecular Weight : 477